Not Rated
|
Fund Size
(0.54% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 12-Nov-25 | 9948.10 | -0.52% | - | 0.08% | 200/240 |
| 1 Month | 17-Oct-25 | 9850.80 | -1.49% | - | 0.75% | 221/239 |
| 3 Month | 19-Aug-25 | 9904.30 | -0.96% | - | 2.82% | 217/235 |
| 6 Month | 19-May-25 | 10401.70 | 4.02% | - | 5.74% | 148/225 |
| YTD | 01-Jan-25 | 9698.50 | -3.02% | - | 4.47% | 176/212 |
| 1 Year | 19-Nov-24 | 10447.70 | 4.48% | 4.48% | 7.15% | 135/198 |
| 2 Year | 17-Nov-23 | 14363.00 | 43.63% | 19.76% | 18.01% | 56/154 |
| 3 Year | 18-Nov-22 | 17664.40 | 76.64% | 20.84% | 18.96% | 44/128 |
| 5 Year | 19-Nov-20 | 22450.70 | 124.51% | 17.55% | 20.66% | 73/104 |
| Since Inception | 02-Jul-18 | 38503.00 | 285.03% | 20.02% | 12.67% | 35/218 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 19-Nov-24 | 12000 | 12287.2 | 2.39 % | 4.45 % |
| 2 Year | 17-Nov-23 | 24000 | 26770.33 | 11.54 % | 10.85 % |
| 3 Year | 18-Nov-22 | 36000 | 47503.94 | 31.96 % | 18.82 % |
| 5 Year | 19-Nov-20 | 60000 | 91600.22 | 52.67 % | 16.92 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 3388.9 | 12.01% | 0.44% | 12.5% (Apr 2025) | 10.74% (Jul 2025) | 20.04 L | 0.00 |
| Divis Laboratories Ltd. | Pharmaceuticals | 2504.4 | 8.88% | 1.12% | 8.88% (Oct 2025) | 5.35% (Nov 2024) | 3.72 L | -5.00 k |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 1808.1 | 6.41% | -0.56% | 7.24% (Jul 2025) | 5.22% (Apr 2025) | 9.56 L | -0.30 L |
| Apollo Hospitals Enterprises Ltd. | Hospital | 1751.6 | 6.21% | -0.02% | 6.37% (Jun 2025) | 4.82% (Dec 2024) | 2.28 L | -4.00 k |
| Cipla Ltd. | Pharmaceuticals | 1528.4 | 5.42% | -0.61% | 7.6% (Feb 2025) | 5.42% (Oct 2025) | 10.18 L | -0.90 L |
| Lupin Ltd. | Pharmaceuticals | 1431.7 | 5.07% | 0.03% | 6.37% (Apr 2025) | 4.94% (Jul 2025) | 7.29 L | 0.00 |
| Fortis Healthcare Ltd. | Hospital | 1220.6 | 4.33% | 0.14% | 4.33% (Oct 2025) | 2.12% (Jan 2025) | 11.93 L | 0.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 1153.1 | 4.09% | -0.24% | 7.62% (Dec 2024) | 4.09% (Oct 2025) | 10.12 L | -0.90 L |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 1133.5 | 4.02% | -0.18% | 6.38% (Dec 2024) | 4.02% (Oct 2025) | 9.46 L | 0.00 |
| Krishna Institute of Medical Sciences Ltd. | Hospital | 1064 | 3.77% | 0.03% | 4.32% (Nov 2024) | 3.57% (Feb 2025) | 14.76 L | 0.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.78% |
| MF Units | MF Units | 0.01% |
| Net Receivables | Net Receivables | -0.10% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | -1.10 | 10.41 | 43.44 | 40.35 | 33.75 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -0.65 | 2.31 | 12.65 | 28.09 | 14.60 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 3.95 | 7.39 | 18.45 | 25.63 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.08 | 4.88 | 18.40 | 22.68 | 0.00 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.70 | 5.80 | 10.90 | 21.22 | 19.82 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | 0.23 | 7.22 | 16.27 | 21.02 | 11.85 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 3.65 | 7.41 | 8.67 | 21.00 | 13.66 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.44 | 5.90 | 7.09 | 20.99 | 0.00 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 3.20 | 6.67 | 8.94 | 20.04 | 17.56 |
| HDFC Banking and Financial Services Fund - Growth | NA | 4362.29 | 3.49 | 6.47 | 7.98 | 18.37 | 16.93 |
Out of 101 mutual fund schemes offered by this AMC, 2 is/are ranked 5 * , 6 is/are ranked 4 * , 5 is/are ranked 3 * , 4 is/are ranked 2 * , and 84 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Mirae Asset Large & Midcap Fund - Growth | 3 | 42980.74 | 1.91 | 5.06 | 8.25 | 11.30 | 17.48 |
| Mirae Asset Large Cap Fund - Regular - Growth | 3 | 41087.55 | 1.72 | 3.98 | 5.84 | 10.98 | 13.26 |
| Mirae Asset ELSS Tax Saver Fund - Regular Plan - Growth | 4 | 27069.09 | 1.73 | 4.60 | 7.47 | 12.03 | 17.44 |
| Mirae Asset Midcap Fund - Regular Plan - Growth | 3 | 18112.14 | 2.37 | 4.99 | 12.08 | 13.16 | 21.14 |
| Mirae Asset Liquid Fund - Growth | 4 | 14283.52 | 0.49 | 1.44 | 2.97 | 6.61 | 6.97 |
| Mirae Asset Aggressive Hybrid Fund - Growth | 3 | 9424.67 | 1.21 | 3.31 | 5.03 | 9.92 | 13.71 |
| Mirae Asset Focused Fund - Growth | 2 | 7979.98 | -0.31 | 1.28 | 3.58 | 5.93 | 11.49 |
| Mirae Asset Great Consumer Fund - Growth | NA | 4769.48 | -1.53 | 0.85 | 6.39 | 7.37 | 17.67 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.46 | 4.46 | 5.38 | 12.10 | 13.69 |
| Mirae Asset Nifty 50 ETF (MAN50ETF) | 4 | 4714.74 | 1.46 | 4.46 | 5.38 | 12.10 | 13.69 |